Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who are ...
During the quarter, we settled our worldwide patent litigation with Bruker on favorable terms and recognized an upfront ...
Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released the following note authored by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback